Sumary of Eyes that received Hydrus microstent less likely to require medications after 5 years:
- November 16, 2021 1 min read Source/Disclosures Published by: Source: Ahmed IK. 5-year results from the HORIZON trial: Long-term safety and effectiveness of combined phacoemulsification and minimally invasive glaucoma surgery with the Hydrus microstent.
- Back to Healio NEW ORLEANS — After 5 years of follow-up, eyes that received the Hydrus microstent for mild to moderate glaucoma required fewer medications and surgeries compared with eyes that underwent cataract surgery alone, according to a study.
- Eyes that received microstent were more likely to be medication-free at 5 years, with 66% of patients not requiring medications vs.
- Additionally, eyes that received a microstent were less likely to require incisional glaucoma surgery, with 2.5% of microstent eyes requiring surgery compared with 6.4% of eyes that underwent cataract surgery alone (P = .
- ” “Not to be dramatic, but I think this is pretty important news in the glaucoma space and in medicine,” Ahmed said during a question and answer session after the presentation.